Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA)

Q: What does CUSIP 68062P106 represent in this 13F holders report?

CUSIP 68062P106 is the security identifier for OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

86 institutional investors reported OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 68062P106

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 87,489,196
Total 13F shares: 36,408,086
Share change: +2,960,890
Total reported value: $328,764,561
Put/Call ratio: 67%
Price per share: $9.03
Number of holders: 86
Value change: +$43,216,272
Number of buys: 55
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 68062P106?
CUSIP 68062P106 identifies OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 68062P106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BVF INC/IL	13F	Company	8.7%	7,611,503	$26,411,915	—	31 Mar 2023	13F
Logos Global Management LP	13F	Company	4.3%	3,743,875	$12,991,246	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	3.5%	3,082,000	$10,695,000	—	31 Mar 2023	13F
Paradigm Biocapital Advisors LP	13F	Company	2.7%	2,382,377	$8,266,848	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.4%	2,085,179	$7,277,264	—	31 Mar 2023	13F
Kynam Capital Management, LP	13F	Company	2.3%	2,011,853	$6,981,130	—	31 Mar 2023	13F
Vivo Capital, LLC	13F	Company	1.9%	1,689,515	$5,862,617	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.7%	1,507,767	$5,231,951	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.4%	1,230,516	$4,269,891	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	1.1%	996,177	$3,456,734	—	31 Mar 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.1%	995,909	$3,455,804	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.66%	575,900	$1,997,000	—	31 Mar 2023	13F
Laurion Capital Management LP	13F	Company	0.59%	513,972	$1,783,483	—	31 Mar 2023	13F
J. Goldman & Co LP	13F	Company	0.51%	447,083	$1,551,378	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.48%	420,000	$1,457,400	—	31 Mar 2023	13F
Newtyn Management, LLC	13F	Company	0.43%	375,000	$1,301,250	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.4%	349,946	$1,214,312	—	31 Mar 2023	13F
Vontobel Holding Ltd.	13F	Company	0.39%	337,917	$1,172,572	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.29%	257,200	$892,000	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.29%	254,718	$883,872	—	31 Mar 2023	13F
EP Wealth Advisors, LLC	13F	Company	0.01%	4,508	$843,231	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.26%	230,568	$800,071	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.26%	230,632	$800,000	—	31 Mar 2023	13F
Monaco Asset Management SAM	13F	Company	0.25%	221,905	$770,010	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.24%	213,312	$740,193	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.24%	205,900	$714,473	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.21%	182,337	$632,709	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.18%	161,433	$560,173	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.14%	121,181	$420,498	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	115,687	$401,434	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.13%	113,890	$395,198	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	88,016	$305,416	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	75,224	$261,000	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.08%	72,992	$253,283	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.07%	58,300	$203,000	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	55,370	$192,134	—	31 Mar 2023	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.06%	51,152	$177,497	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	40,895	$141,906	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.04%	35,700	$123,879	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	29,393	$101,994	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.03%	29,150	$101,000	—	31 Mar 2023	13F
CONWAY CAPITAL MANAGEMENT, INC.	13F	Company	0.03%	26,500	$91,955	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.03%	23,943	$83,082	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.02%	19,644	$68,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	18,580	$64,473	—	31 Mar 2023	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	16,225	$56,301	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	15,161	$52,609	—	31 Mar 2023	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.01%	12,745	$44,000	—	31 Mar 2023	13F
ALGERT GLOBAL LLC	13F	Company	0.01%	12,450	$43,000	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.01%	12,200	$42,334	—	31 Mar 2023	13F

Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q2 2023

As of 30 Jun 2023, Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,408,086 shares. The largest 10 holders included BVF INC/IL, Logos Global Management LP, Paradigm Biocapital Advisors LP, Cormorant Asset Management, LP, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Vivo Capital, LLC, Kynam Capital Management, LP, and SECTORAL ASSET MANAGEMENT INC. This page lists 86 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.